clinical trials

Recent Rosacea Blog Posts

Dermata DMT 210 works for redness and bumps of rosacea

A press release today highlighting a new drug, based on Arazine, that is claimed to help both the redness and papules and pustules of rosacea through its ability to down regulate G-protein coupled receptor (GPCR) signaling. The company developing DMT 210, Dermata, is releasing results from their phase 1 trials, and are looking to commence phase 2 trials […]

Continue Reading

Dr. Reddy trialing Topical Itraconazole 5% (DFD-04)

Dr. Reddy has listed a clinical trial to continue to investigate Topical Itraconazole 5% as a treatment for the papules and pustules of rosacea. So we can add DFD-04 to the list of new drugs in development for rosacea. From Dr. Reddy’s 2015 Investor Day Presentation. We target underserved segments within large disease areas both […]

Continue Reading

Trial to chase how Soolantra works

A clinical trial supported by Galderma is to be conducted at UCSD to determine via changes in inflammatory markers, how Ivermectin works to relieve rosacea symptoms. After 12 weeks participants will be examined to determine changes in serine protease activity and expression of cathelicidin (LL-37) mRNA. Any changes found in these inflammatory markers will be correlated […]

Continue Reading

Timolol (Timoptic) for the redness of rosacea

The glaucoma treament Timolol is to be trialed as a treatment for the facial redness of rosacea. Timolol is a non-selective beta-adrenergic receptor antagonist, somewhat similar to Brimonidine. Mirvaso is the recently approved treatment for the red face of rosacea that is based on bromonidine. Timolol has been used in the past as a dermatological agent […]

Continue Reading

Omiganan still in the rosacea pipeline

There aren’t many drugs currently in late development for rosacea. Finacea foam and Soolantra have been approved, and it looks like Azultro is on the way. One of the remaining drugs that is still inching its way through the approval process is Omiganan. Confirmation that Omiganan is still alive in the rosacea development pipeline comes from […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.